OncoVista Innovative Therapies Inc (OVIT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 23, 16:00
OncoVista Innovative Therapies Cash from Financing (TTM): 0.25M for Sept. 30, 2015
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2015 | 0.25M |
June 30, 2015 | 0.29M |
March 31, 2015 | 0.31M |
December 31, 2014 | 0.20M |
September 30, 2014 | 0.20M |
June 30, 2014 | 0.10M |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | -0.06M |
March 31, 2013 | -0.0597M |
December 31, 2012 | -0.0597M |
September 30, 2012 | -0.0597M |
June 30, 2012 | 0.0083M |
March 31, 2012 | 0.0081M |
December 31, 2011 | 0.0081M |
September 30, 2011 | -2.269M |
June 30, 2011 | -2.165M |
March 31, 2011 | -2.063M |
December 31, 2010 | -1.968M |
Date | Value |
---|---|
September 30, 2010 | 0.4215M |
June 30, 2010 | 0.4526M |
March 31, 2010 | 0.3513M |
December 31, 2009 | 1.006M |
September 30, 2009 | 0.8886M |
June 30, 2009 | 0.75M |
March 31, 2009 | 0.5525M |
December 31, 2008 | -0.1926M |
September 30, 2008 | -0.4227M |
June 30, 2008 | 5.828M |
March 31, 2008 | 6.025M |
December 31, 2007 | 6.000M |
September 30, 2007 | 8.553M |
June 30, 2007 | 2.383M |
March 31, 2007 | 2.435M |
December 31, 2006 | 2.496M |
September 30, 2006 | 0.2257M |
June 30, 2006 | 0.1933M |
March 31, 2006 | 0.1294M |
December 31, 2005 | 0.1391M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
FluoroPharma Medical Inc | 0.6153M |
RenovaCare Inc | -- |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | 0.7741M |
Regenerx Biopharmaceuticals Inc | -- |